[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 13, Issue 3 (5-2011) ::
J Babol Univ Med Sci. 2011; Volume 13 Back to browse issues page
Comparison of the Effect of Mefenamic Acid and Matricaria Camomilla Capsules on Primary Dysmenorrhea
M Modarres, * , M Mirmohhamad Ali, , Z Oshrieh , A Mehran
Abstract:   (7944 Views)
BACKGROUND AND OBJECTIVE: The most common pelvic cyclic pain and the most common complaint of gynecologic patients is dysmenorrhea that causes many personal and social problems. Mefenamic acid with a lot of side effects and matricaria camomilla are useful for treatment of primary dysmenorrhea. The aim of this study was to compare the effect of mefenamic acid and matricaria camomilla capsules on primary dysmenorrhea.
METHODS: This cross over, triple-blind randomized clinical trial study was performed on 80 students with primary dysmenorrhea, staying in Tehran University dormitory. They were randomly allocated to mefenamic acid and matricaria camomilla groups. Research took place in three stages. In the first stage, all students for two consecutive cycles in regard to suffering from second or third degree dysmenorrhea were examined. In the second stage, mefenamic acid or matricaria camomilla capsules with check list for the amount of bleeding and VAS scale were randomly given to each of the research units. In the third stage, each research unit received the same treatment of the opposite group with the same characteristics (crossover treatment) and for another two consecutive cycles this same method with replacing the medicine was repeated again. Each person was studied for 6 cycles. The patient marked the intensity of their pain on the visual analogue scale an hour before taking the first dose of the medicine and also 1 hour, 2 hours, 4 hours, and 48 hours after taking the first dose.
FINDINGS: The mean age in both groups was 24.72±2.55 years. The mean of pain severity before treatment was 4.65±0.47 and after treatment was 2.80±1.04 and 1.12±0.43 in the mefenamic acid and matricaria camomilla groups, respectively that in comparison to the sign of pain it was revealed that the severity of pain decreased after two treatment cycles in the two groups receiving mefenamic acid and matricaria camomilla capsules. But this decrease in the matricaria camomilla group was considerable (p<0.001).
CONCLUSION: The results of this study showed that taking matricaria camomilla capsule can decrease the severity of dysmenorrhea, so it is recommended to use it in the treatment of this common gynecologic disorder in women.
Keywords: Matricaria camomilla, Mefenamic acid, Dysmenorrhea
Full-Text [PDF 223 kb]   (2253 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/7 | Published: 2014/06/7


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Modarres, M, Mirmohhamad Ali, M, Oshrieh Z, Mehran A. Comparison of the Effect of Mefenamic Acid and Matricaria Camomilla Capsules on Primary Dysmenorrhea. J Babol Univ Med Sci 2011; 13 (3) :50-58
URL: http://jbums.org/article-1-3803-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 3 (5-2011) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.05 seconds with 43 queries by YEKTAWEB 4645